Breast Biopsy Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Breast Biopsy Devices Market Report is Segmented by Product (Breast Biopsy Needles, Breast Biopsy Tables, Localization Wires and Others), by Procedure (Vacuum Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy, Liquid Biopsy, and Surgical Biopsy ), by Technique (Image Guided Biopsy, Liquid Biopsy), by Indication (Fibroadenoma, Suspicious Micro-Calcifications, Complex Cyst, Recurrent Breast Cancer, Invasive Lobular Carcinoma, and Others), by End User(Breast Care Centers, Hospitals and Clinics, and Diagnostic Centers) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Breast Biopsy Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Breast Biopsy Devices Industry Overview

The breast biopsy devices market is moderately consolidated and competitive due to the presence of many players. The market's major players are concentrating on joint ventures, strategic alliances, the introduction of new products, and geographic growth into developing and economically advantageous areas. Some of the major players include F. Hoffmann-La Roche Ltd, Ferring B.V., Hologic Inc., Danaher Corporation, Argon Medical Devices, Merit Medical Systems, Menarini-Silicon Biosystems, NeoGenomics, Sterylab S.R.L., Bio-Rad Laboratories, Inc., Qiagen, Exact Sciences Corporation, Sysmex Inostics, Becton Dickinson and Company, Guardant Health, Inc.

Breast Biopsy Devices Market Leaders

  1. F. Hoffmann-La Roche Ltd

  2. Becton Dickinson and Company

  3. Danaher Corporation

  4. Merit Medical Systems

  5. *Disclaimer: Major Players sorted in no particular order
Breast Biopsy Devices Market Concentration